Accelerator Programmes For Start-Ups: Supporting Your Transition From Lab To Marketplace Amy Cotterill2024-11-28T14:01:28+00:00March 19th, 2024|Accelerator, Article|
Effective Life Sciences Communications: Engaging Your AudienceAmy Cotterill2024-03-01T15:53:35+00:00March 1st, 2024|Accelerator, Article|
Pioneer Group Leads $2.34m Investment In Neobe Therapeutics’ Cancer Therapy InnovationVicky Coghlan2024-11-28T14:25:26+00:00February 29th, 2024|Investment, News|
BioCity Glasgow: BioAscent Invests In New State-Of-The-Art Protein Production FacilityVicky Coghlan2024-11-28T14:25:44+00:00February 23rd, 2024|BioCity Glasgow, Investment, News|
IsomAb Closes £7.5m Financing To Drive New Diabetic TreatmentVicky Coghlan2024-11-28T14:26:00+00:00February 21st, 2024|BioCity Nottingham, Investment, News|
MIP Discovery Raises £7m To Advance CommercialisationVicky Coghlan2024-11-28T14:26:13+00:00February 21st, 2024|Colworth Park, Investment, News|
Pioneer Group’s Regeneration Plans For Cambridge’s Grafton Centre ApprovedVicky Coghlan2024-11-28T14:01:45+00:00February 8th, 2024|Article, Headline News, News|
Start-Up Funding: Five Things Investors Look For In Life Sciences CompaniesAmy Cotterill2025-04-11T14:38:51+01:00January 31st, 2024|Article, Investment|
What Start-Up Support Is Available For Budding Life Science Businesses?Amy Cotterill2024-11-28T14:02:13+00:00December 11th, 2023|Article, Cherrywood|
Operational Excellence Will Be Key In A Maturing Life Sciences MarketVicky Coghlan2024-11-28T14:02:51+00:00November 21st, 2023|Article, Investment, News|
